If your child is at least 10 and under the age of 18 and struggling with insomnia, this study could be for you. An experienced team of researchers is evaluating a medication called Daridorexant, already proven effective and safe in adults, to understand its potential benefits and safety in the younger population.

Eligibility:

• Your child is between 10 and 17 years old.
• Your child struggles with falling asleep and/or staying asleep.
• Chronic insomnia disorder (problems falling asleep, waking up multiple times during the night, early morning awakenings)
• Sleep disturbances have been present for at least 3 months.
• Sleep disturbances occur at least three nights per week.
• Your child does not take naps longer than 1 hour on 3 weekdays per week during the three months before prescreening.
• Sleep problems persist despite adequate time and opportunity for sleep.
• Sleep problems impact daily performance.

There are additional eligibility criteria, which the study team will discuss with participants. If you are interested, additional eligibility criteria will be assessed by the study doctor or staff. Fill out the form to see if you qualify today!